Publication | Open Access

Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

ThrombosisNeurobiology Of DiseaseIschemic StrokeCardiovascular DiseaseMedicineNeurological MonitoringCerebrovascular DiseasePlacebo-controlled TrialRehabilitationNeurologyPharmacotherapyCerebral Blood FlowPublic HealthStrokeNeurological AssessmentIschemic SyndromeIschaemic Stroke